We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-13.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.1B
AUM Growth
-$8.74B
(-19%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
799
New
91
Increased
212
Reduced
361
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$347M |
| 2 |
Wayfair
W
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$140M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$131M |
| 5 |
CVS Health
CVS
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$946M |
| 2 |
SHPG
Shire pic
SHPG
|
+$472M |
| 3 |
Deere & Co
DE
|
+$326M |
| 4 |
COL
Rockwell Collins
COL
|
+$286M |
| 5 |
ANDV
Andeavor
ANDV
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Technology | 13.74% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
426
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $13.9M | 0.04% |
+138,000
| New | +$14.3M |
|
|
FITB
427
Fifth Third Bancorp
FITB
$51.2B
| $13.9M | 0.04% |
+590,200
| New | +$15.5M |
|
428
Regeneron Pharmaceuticals
REGN
$78.5B
| $13.8M | 0.04% |
37,021
-52,200
| -59% | -$19.1M |
|
429
Corpay
CPAY
$25B
| $13.8M | 0.04% |
74,100
-87,900
| -54% | -$17.2M |
|
|
KNL
430
DELISTED
Knoll, Inc.
KNL
| $13.7M | 0.04% |
+830,843
| New | +$16.2M |
|
431
Ovintiv
OVV
$17.3B
| $13.7M | 0.04% |
+472,420
| New | +$20.4M |
|
432
Synopsys
SNPS
$74.4B
| $13.6M | 0.04% |
161,400
-7,600
| -4% | -$675K |
|
|
ALXN
433
DELISTED
Alexion Pharmaceuticals
ALXN
| $13.5M | 0.04% |
139,062
-55,130
| -28% | -$6.52M |
|
434
UDR
UDR
$12.3B
| $13.5M | 0.04% |
341,600
+2,300
| +0.7% | +$92.9K |
|
435
Cboe Global Markets
CBOE
$32.5B
| $13.5M | 0.04% |
137,700
-6,800
| -5% | -$708K |
|
436
Builders FirstSource
BLDR
$7.15B
| $13.5M | 0.04% |
1,233,908
+533,908
| +76% | +$6.71M |
|
437
Lamb Weston
LW
$7.22B
| $13.4M | 0.04% |
+182,500
| New | +$14M |
|
438
Cardinal Health
CAH
$53.9B
| $13.3M | 0.04% |
297,400
-102,000
| -26% | -$5.32M |
|
439
Vornado Realty Trust
VNO
$7.41B
| $13.2M | 0.04% |
213,259
-10,500
| -5% | -$719K |
|
440
Cencora
COR
$60.6B
| $13.2M | 0.04% |
176,800
-32,600
| -16% | -$2.81M |
|
441
J.M. Smucker
SJM
$12.7B
| $13.1M | 0.04% |
140,627
+211
| +0.2% | +$22K |
|
442
Mid-America Apartment Communities
MAA
$15.4B
| $13.1M | 0.04% |
137,150
-6,900
| -5% | -$684K |
|
443
Arrow Electronics
ARW
$11.1B
| $12.9M | 0.04% |
187,769
-166,000
| -47% | -$11.8M |
|
444
Conagra Brands
CAG
$6.94B
| $12.9M | 0.04% |
605,545
+147,006
| +32% | +$4.75M |
|
445
Dover
DOV
$27.6B
| $12.9M | 0.04% |
+181,304
| New | +$14.8M |
|
446
Chipotle Mexican Grill
CMG
$47.2B
| $12.9M | 0.04% |
1,489,150
-75,000
| -5% | -$678K |
|
447
Indaptus Therapeutics
INDP
$172M
| $12.8M | 0.04% |
759
-145
| -16% | -$1.98M |
|
448
Lennar Class A
LEN
$19.8B
| $12.8M | 0.04% |
337,809
-18,284
| -5% | -$745K |
|
449
Molson Coors Class B
TAP
$7.79B
| $12.8M | 0.04% |
227,736
-11,400
| -5% | -$702K |
|
450
West Pharmaceutical
WST
$24B
| $12.7M | 0.04% |
130,000
-20,000
| -13% | -$2.17M |
|
Similar funds
Adage Capital Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Adage Capital Partners held 799 positions worth $36.1B, down 19% from $44.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Adage Capital Partners withdrew a net $2.16B in Q4 2018, closing 95 positions and reducing 361 holdings. Its most notable exit was Aetna Inc, an estimated $946M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in CVS Health worth $106M.
- Adage Capital Partners's largest Q4 2018 buy was CVS Health: 1,619,774 shares worth $106M.
- Adage Capital Partners added most to GE Aerospace in Q4 2018, an estimated $347M increase.
- Adage Capital Partners's biggest Q4 2018 reduction was Shire pic, cutting an estimated $472M.
- Adage Capital Partners fully exited Aetna Inc in Q4 2018, selling an estimated $946M.
- Adage Capital Partners's ten largest holdings make up 16% of its $36.1B portfolio in Q4 2018.
- Adage Capital Partners opened 91 new positions and closed 95 in Q4 2018.
- Adage Capital Partners's portfolio value fell 19% quarter-over-quarter to $36.1B.
Based on Adage Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.